Clinical and Cost Impact Analysis of a Novel Prognostic Test for Early Detection of Preterm Birth.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Cost-Effectiveness of a Proteomic Test for Preterm Birth Prediction.ClinicoEconomics and outcomes research : CEOR · 2021
   Article
2. Effects of Selective Exclusion of Patients on Preterm Birth Test Performance.Obstetrics and gynecology · 2019
   Article
3. Cervical hyaluronan biology in pregnancy, parturition and preterm birth.Matrix biology : journal of the International Society for Matrix Biology · 2019
   Review
4. The pathophysiology of human premature cervical remodeling resulting in spontaneous preterm birth: Where are we now?Seminars in perinatology · 2017
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

6 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as